Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity - Virhammar, J; Nääs, A; Fällmar, D; Cunningham, JL; Klang, A; Ashton, NJ (Eur J Neurol, 2021)